These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 23023859

  • 1. Exploratory study of community pharmacists' perceptions about new or transferred prescription incentives.
    Fleming M, Nemlekar P, Brown CM, Cantu R.
    J Am Pharm Assoc (2003); 2012; 52(5):e53-8. PubMed ID: 23023859
    [Abstract] [Full Text] [Related]

  • 2. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
    Varisco TJ, Ogunsanya ME, Barner JC, Fleming ML.
    J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
    [Abstract] [Full Text] [Related]

  • 3. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S.
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
    Moczygemba LR, Barner JC, Roberson K.
    J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database.
    Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S.
    Res Social Adm Pharm; 2014; 10(2):285-96. PubMed ID: 23816495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. General practitioners' perceptions of pharmacists' new services in New Zealand.
    Hatah E, Braund R, Duffull S, Tordoff J.
    Int J Clin Pharm; 2012 Apr; 34(2):364-73. PubMed ID: 22359183
    [Abstract] [Full Text] [Related]

  • 14. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA, Layson-Wolf C, de Bittner MR, Owen JA, Haupt S.
    J Am Pharm Assoc (2003); 2009 Apr; 49(3):392-8. PubMed ID: 19443319
    [Abstract] [Full Text] [Related]

  • 15. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS, Reddel HK, Bosnic-Anticevich SZ.
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [Abstract] [Full Text] [Related]

  • 16. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V, Hansford D, Cunningham S, Stewart D.
    Res Social Adm Pharm; 2014 Aug; 10(1):88-105. PubMed ID: 23665077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
    Thornton JD, Lyvers E, Scott VGG, Dwibedi N.
    J Am Pharm Assoc (2003); 2017 Aug; 57(2S):S12-S18.e4. PubMed ID: 28163027
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.